Adult Schedule
The recommended healthcare preventive needs are constantly changing. For example, an annual physical/medical examination is not always recommended or necessary. Although your personal health could impact these recommendations, the schedules below can help recommend the services that should be considered based upon your age.
-
Screening Recommendations for Females: 18-39 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk women: 18-39 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Breast Cancer --- Cervical cancer Ages 21 to 29 years: every 3 years
Ages 30 to 39 years: every 3 to 5 years
Colorectal cancer Consider if increased risk Depression Every year Diabetes Every 3 years if hypertension, BMI > 25, or history of gestational diabetes Fall risk --- Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV At least one lifetime screen for all age groups; may offer additional screening for adolescents and adults at high risk of HIV infection Hyperlipidemia (coronary artery disease) Screen initially at age 20 years, then resume no later than age 40 years unless screening is abnormal or coronary disease risks develop Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia --- Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Age < 25 years: Every year if sexually active
Age > 25 years: Every year if increased risk
Tobacco use Every year Vaccinations for healthy women Influenza (IIV, LAIV, and RIV) Every year Pneumococcus (PCV13 and PPSV23) --- Tetanus diphtheria acellular pertussis (Tdap and Td) Substitute 1-time dose of Tdap for Td booster, then boost with Td every 10 years Human papillomavirus (HPV) Offer at ages 9 to 26 years and complete series at any age; HPV vaccination is not recommended in pregnant women Herpes zoster or shingles (HZV) --- Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, and measles-mumps-rubella vaccines depending on age and risk factors Meningococcal B (MenB) Preferred at ages 16 to 18 years but optional at ages 16 to 23 years (when using Bexsero, administer 2 doses at least 1 month apart) -
Screening Recommendations for Females: 40-49 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk women: 40-49 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Breast Cancer Every year Cervical cancer Every 3 to 5 years Colorectal cancer Consider if increased risk Depression Every year Diabetes Every 3 years beginning at age 45 years Fall risk --- Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV At least one lifetime screen for all age groups; may offer additional screening for adolescents and adults at high risk of HIV infection Hyperlipidemia (coronary artery disease) Every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia --- Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if increased risk
Tobacco use Every year Vaccinations for healthy women Influenza (IIV, LAIV, and RIV) Every year Pneumococcus (PCV13 and PPSV23) --- Tetanus diphtheria acellular pertussis (Tdap and Td) Substitute 1-time dose of Tdap for Td booster, then boost with Td every 10 years Human papillomavirus (HPV) Offer at ages 9 to 26 years and complete series at any age; HPV vaccination is not recommended in pregnant women Herpes zoster or shingles (HZV) --- Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, and measles-mumps-rubella vaccines depending on age and risk factors Meningococcal B (MenB) Preferred at ages 16 to 18 years but optional at ages 16 to 23 years (when using Bexsero, administer 2 doses at least 1 month apart) -
Screening Recommendations for Females: 50-64 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk women: 50-64 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Breast Cancer Every year Cervical cancer Every 3 to 5 years Colorectal cancer Initiate average-risk screening Depression Every year Diabetes Every 3 years Fall risk --- Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV At least one lifetime screen for all age groups; may offer additional screening for adolescents and adults at high risk of HIV infection Hyperlipidemia (coronary artery disease) Every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia Screening if increased risk Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if increased risk Tobacco use Every year Vaccinations for healthy women Influenza (IIV, LAIV, and RIV) Every year Pneumococcus (PCV13 and PPSV23) --- Tetanus diphtheria acellular pertussis (Tdap and Td) Substitute 1-time dose of Tdap for Td booster, then boost with Td every 10 years Human papillomavirus (HPV) --- Herpes zoster or shingles (HZV) 2 doses at age > 50 years unless contraindicated Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, and measles-mumps-rubella vaccines depending on age and risk factors Meningococcal B (MenB) Preferred at ages 16 to 18 years but optional at ages 16 to 23 years (when using Bexsero, administer 2 doses at least 1 month apart) -
Screening Recommendations for Females: 65 and older
Screening, immunization, and prevention schedule for asymptomatic average-risk women: 50-64 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Breast Cancer Ages 65 to 75 years: every year Cervical cancer No screening if adequate negative prior screening and patient not high risk Colorectal cancer Ages 65 to 75 years (life expectancy > 10 years): Continue screening
Ages 76 to 85 years (life expectancy > 10 years): Screen patients who have never been screened; continued screening of other patients has uncertain benefit
Depression Every year Diabetes Every 3 years Fall risk Every year Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV At least one lifetime screen for all age groups; may offer additional screening for adolescents and adults at high risk of HIV infection Hyperlipidemia (coronary artery disease) Ages 65 to 75 years: Consider every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia Screening bone density measurement at age 65 years Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if increased risk Tobacco use Every year Vaccinations for healthy women Influenza (IIV, LAIV, and RIV) Every year Pneumococcus (PCV13 and PPSV23) 1-time dose of PCV13 and 1-time dose of PPSV23 Tetanus diphtheria acellular pertussis (Tdap and Td) Substitute 1-time dose of Tdap for Td booster, then boost with Td every 10 years Human papillomavirus (HPV) --- Herpes zoster or shingles (HZV) 1-time dose if not yet given, unless contraindicated Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, and measles-mumps-rubella vaccines depending on age and risk factors Meningococcal B (MenB) Preferred at ages 16 to 18 years but optional at ages 16 to 23 years (when using Bexsero, administer 2 doses at least 1 month apart) -
Screening Recommendations for Males: 18-39 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk men: 18-39 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Abdominal aortic aneurysm --- Alcohol abuse Every year Colorectal cancer Consider if increased risk Depression Every year Diabetes Every 3 years if hypertension or BMI > 25 Fall risk --- Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV At least one lifetime screen for all age groups; may offer additional screening for adolescents and adults at high risk of HIV infection Hyperlipidemia (coronary artery disease) Screen initially at age 20 years, then resume no later than age 40 years unless screening is abnormal or coronary disease risks develop Hypertension Every 2 years if average risk; every year if increased risk Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia --- Prostate cancer --- Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if increased risk Tobacco use Every year Vaccinations for healthy women Influenza (IIV, LAIV, and RIV) Every year Pneumococcus (PCV13 and PPSV23) --- Tetanus diphtheria acellular pertussis (Tdap and Td) Substitute 1-time dose of Tdap for Td booster, then boost with Td every 10 years Human papillomavirus (HPV) Offer at ages 9 to 26 years and complete series at any age Herpes zoster or shingles (HZV) --- Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, and measles-mumps-rubella vaccines depending on age and risk factors Meningococcal B (MenB) Preferred at ages 16 to 18 years but optional at ages 16 to 23 years (when using Bexsero, administer 2 doses at least 1 month apart) -
Screening Recommendations for Males: 50-64 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk men: 50-64 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Abdominal aortic aneurysm --- Alcohol abuse Every year Colorectal cancer Initiate average-risk screening Depression Every year Diabetes Every 3 years beginning at age 45 years Fall risk --- Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV At least one lifetime screen for all age groups; may offer additional screening for adolescents and adults at high risk of HIV infection Hyperlipidemia (coronary artery disease) Every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia Screen if increased risk Prostate cancer Consider shared decision-making, including discussion of risks and benefits Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if increased risk Tobacco use Every year Vaccinations for healthy women Influenza (IIV, LAIV, and RIV) Every year Pneumococcus (PCV13 and PPSV23) --- Tetanus diphtheria acellular pertussis (Tdap and Td) Substitute 1-time dose of Tdap for Td booster, then boost with Td every 10 years Human papillomavirus (HPV) Offer at ages 9 to 26 years and complete series at any age Herpes zoster or shingles (HZV) 2 doses at age > 50 years unless contraindicated Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, and measles-mumps-rubella vaccines depending on age and risk factors Meningococcal B (MenB) Preferred at ages 16 to 18 years but optional at ages 16 to 23 years (when using Bexsero, administer 2 doses at least 1 month apart) -
Screening Recommendations for Males: 40-49 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk men: 40-49 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Abdominal aortic aneurysm --- Alcohol abuse Every year Colorectal cancer Consider if increased risk Depression Every year Diabetes Every 3 years beginning at age 45 years Fall risk --- Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV At least one lifetime screen for all age groups; may offer additional screening for adolescents and adults at high risk of HIV infection Hyperlipidemia (coronary artery disease) Every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia --- Prostate cancer --- Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if increased risk Tobacco use Every year Vaccinations for healthy women Influenza (IIV, LAIV, and RIV) Every year Pneumococcus (PCV13 and PPSV23) --- Tetanus diphtheria acellular pertussis (Tdap and Td) Substitute 1-time dose of Tdap for Td booster, then boost with Td every 10 years Human papillomavirus (HPV) Offer at ages 9 to 26 years and complete series at any age Herpes zoster or shingles (HZV) --- Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, and measles-mumps-rubella vaccines depending on age and risk factors Meningococcal B (MenB) Preferred at ages 16 to 18 years but optional at ages 16 to 23 years (when using Bexsero, administer 2 doses at least 1 month apart) -
Screening Recommendations for Males: 65 and older
Screening, immunization, and prevention schedule for asymptomatic average-risk men: 50-64 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Abdominal aortic aneurysm 1-time screen between ages 65 and 75 if smoking history and beyond if life expectancy > 10 years Alcohol abuse Every year Colorectal cancer Ages 65 to 75 years (life expectancy > 10 years): Continue screening
Ages 76 to 85 years (life expectancy > 10 years): Screen patients who have never been screened; continued screening of other patients has uncertain benefit
Depression Every year Diabetes Every 3 years Fall risk Every year Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV At least one lifetime screen for all age groups; may offer additional screening for adolescents and adults at high risk of HIV infection Hyperlipidemia (coronary artery disease) Ages 65 to 75 years: Consider every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia Screen at age 70 years, if increased risk Prostate cancer Consider shared decision-making, including discussion of risks and benefits Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if increased risk Tobacco use Every year Vaccinations for healthy women Influenza (IIV, LAIV, and RIV) Every year Pneumococcus (PCV13 and PPSV23) 1-time dose of PCV13 and 1-time dose of PPSV23 Tetanus diphtheria acellular pertussis (Tdap and Td) Substitute 1-time dose of Tdap for Td booster, then boost with Td every 10 years Human papillomavirus (HPV) --- Herpes zoster or shingles (HZV) 1-time dose if not yet given, unless contraindicated Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, and measles-mumps-rubella vaccines depending on age and risk factors Meningococcal B (MenB) Preferred at ages 16 to 18 years but optional at ages 16 to 23 years (when using Bexsero, administer 2 doses at least 1 month apart)